THE NOVEL FARNESOID X RECEPTOR LIGAND TC-100 PROTECTS FROM LIVER INJURY VIA MODULATION OF THE INTESTINAL MICROBIOTA

Raffaella Gadaleta  ¹     Marinella Marzano  ²     Daniela Passeri  ³     Marianna Intranuovo  ³     Luciano Adorini  ⁴     Graziano Pesole  ⁴     Roberto Pellicciari  ⁴     Antonio Moschetta  ^4    
1 University of Bari, Bari, Italy
² National Research Council, Bari, Italy
³ TES Pharma, Perugia, Italy
⁴ Intercept Pharmaceuticals, New York, United States

Topic
Disease Mechanisms, Gut Microbiota, Hepatobiliary, Histopathology

Session
Liver diseases: From bench to bedside

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)